The global conjunctivitis market size was valued at US$ 4.39 Billion in 2020 and is projected to reach US$ 6.85 Billion by 2030, rising at a market growth (CAGR) of 3.65% during the forecast period. Precedence Research’s latest report on the global conjunctivitis market provides an analysis for the period of 2017 to 2030, wherein, 2020 is the base year, 2017 and before is historical data, and 2021 to 2030 is the forecast period.
Precedence Research provides an in-depth analysis of market size, share analysis, Industry growth, market valuation, market dynamics which includes drivers, restraints, opportunities, trends, challenges, market segmentation, competitive landscape, regional and country breakdowns, and strategies for conjunctivitis market. The study reviews the global industry by-products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context, and more.
The report comprises a detailed value chain analysis, which provides a comprehensive view of this market. The Porter’s Five Forces model for the global market has also been included to help understand the competitive landscape. The study covers market attractiveness analysis, wherein resin types are benchmarked based on their market value, growth rate, and general attractiveness.
Download FREE SAMPLE PAGES before Purchase @ https://www.precedenceresearch.com/sample/1230
Conjunctivitis is a contamination of the conjunctiva, a slim membrane layering the white portion of the sclera, eye, or the internal surface of the lids. Conjunctivitis can be very contagious and expand easily within large collections of people. Occasionally, especially in children, the ailment can affect visualization. In such situations, clinicians need to be knowledgeable immediately for effective and primary treatment.
Causes of Conjunctivitis:
- Irritant such as Chemicals
Type of conjunctivitis:
Based on the different agents leading to conjunctivitis, the condition can be classified into the following types.
When the eye’s ability to resist bacterial infections is compromised, conjunctival infection occurs. This can happen during serious illnesses or in immunocompromised individuals. Bacteria such as Streptococcus pneumoniae, the Moraxella species, the Hemophilus species, and the Staphylococcus species can lead to infection. Bacterial conjunctivitis can be further classified into the following types.
Viral conjunctivitis is caused by viruses and is found to be associated with upper respiratory tract infections. It is a highly contagious condition that begins in one eye and often spreads to the other. As antibiotics do not cure this type of infection, infected individuals must wait for the condition to ease by itself. Medical attention is essential if the infection lasts for over seven days. Adenoviruses and herpes viruses are commonly associated with viral conjunctivitis.
The conjunctiva, when exposed to the environment, is often associated with allergic and immune-mediated reactions, which lead to allergic conjunctivitis. In this condition, type 1 hypersensitivity reactions occur when an allergen reacts with IgE antibodies, resulting in mast cell degranulation and release of inflammatory mediators. Allergic conjunctivitis can be further classified into the following types.
Factors such as increasing prevalence of conjunctivitis, increasing healthcare expenditure, rising exposure to allergens, highly contagious nature of conjunctivitis are driving the growth of conjunctivitis market. Moreover, Additional features that are expected to fuel this business are integration of latest technologies and growing investment by major players.
Smoking affects the ocular surface, resulting in redness, itchiness, and irritation of the eyes. This can cause atopic keratoconjunctivitis and allergic conjunctivitis due to decreased conjunctival sensitivity. Industrialization, especially the automobile industry, involves high levels of pollutants and chemicals. Exposure to diesel exhausts increases the density of inflammatory cells, such as IL-6 and intercellular adhesion molecule-1, leading to the development of allergic conjunctivitis. This will drive the growth of the conjunctivitis medication market, as more individuals will require treatment.
- Among the type segment, allergic conjunctivitis dominated the overall market in 2020. High prevalence of allergic conjunctivitis due to high exposure to allergen is the foremost factors attributing to its large market share.
- The adults segment accounted for the major share of revenue in the patient type segment with more than 63% share in 2020 due to high incidence of conjunctivitis in adults. Pediatric segment is anticipated to grow at the uppermost CAGR through the forecast duration.
- Anti-histaminic accounted for the largest revenue in the drug-class segment. Use of anti-histaminic for the management of allergic conjunctivitis is the key reason for high market share. Steroid Drugs segment is expected to grow at the highest growth rate through the estimate duration.
- Allegran, Pfizer Inc, Atopix Therapeutics Ltd. accounted for a significant share of the global conjunctivitis market.
Key Players of the global conjunctivitis market are:
- Atopix Therapeutics Ltd.
- Ocular Therapeutix, Inc.
- Santen Pharmaceutical Co. Ltd.
- Boehringer Ingelheim
- Pfizer Inc
- Sun Pharma
- Sirion Therapeutics, Inc.
Segments Covered in the Report:
- Bacterial Conjunctivitis
- Viral Conjunctivitis
- Allergic Conjunctivitis
By Patients Type
By Drug Class
- Steroid Drugs
- North America (United States, Canada)
- Europe (Germany, France, UK, Italy, Russia, and Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia, Korea, and Rest of Asia Pacific)
- Latin America (Brazil and the Rest of Latin America)
- The Middle East and Africa (GCC, North Africa, South Africa, and Rest of the Middle East & Africa)
The report includes information for Asia Pacific, North America, Latin America, Europe, Middle East, and Africa. In 2020, the North America region dominated the worldwide market with a market share of higher than 43%. The U.S. indicated the highest slice in North America principally due to early application of latest technologies. Moreover, availability of latest healthcare infrastructure also supported the high market portion of North America.
Europe was the subsequent significant market chiefly due to presence of skilled physicians. Presence of major companies in the European region is also expected to lift the demand for conjunctivitis in the anticipated time-span. The Asia Pacific region is projected to grow at the highest CAGR of around 5.35% in the estimate period due to increasing healthcare expenditure. Latin America and Middle East and African region will display noticeable growth.
Purchase this Market Research Report @ https://www.precedenceresearch.com/checkout/1230
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and among different ventures present globally.
Call: +1 9197 992 333
Carolina is an author who specializes in covering healthcare, chemical, and the automotive industry. Before joining Market Stats News, Carolina covered some of the biggest companies in Silicon Valley for the San Jose Mercury News. She loves all things French and the written word. Articles by Carolina